J FRONTIER CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,401 JPY | +0.92% |
|
-0.25% | -44.16% |
| Sales 2022 | 11.88B 74.97M 6B | Sales 2023 | 16.84B 106M 8.52B | Capitalization | 11.12B 70.2M 5.62B |
|---|---|---|---|---|---|
| Net income 2022 | 400M 2.53M 202M | Net income 2023 | -1.9B -11.99M -960M | EV / Sales 2022 | 0.68 x |
| Net cash position 2022 | 2.41B 15.22M 1.22B | Net Debt 2023 | 486M 3.07M 246M | EV / Sales 2023 | 0.69 x |
| P/E ratio 2022 |
26.5
x | P/E ratio 2023 |
-5.77
x | Employees | 255 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.18% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.92% | ||
| 1 week | -0.25% | ||
| Current month | -25.55% | ||
| 1 month | -26.46% | ||
| 3 months | -39.14% | ||
| 6 months | -38.36% | ||
| Current year | -44.16% |
1 week
2 372.00
2 545.00
1 month
2 360.003 280.00
Current year
2 360.004 530.00
1 year
2 303.005 830.00
3 years
1 620.005 830.00
5 years
1 620.005 830.00
10 years
1 620.005 830.00
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 43 | 31/05/10 | |
Shinji Otabe
ADM | Chief Administrative Officer | 37 | 30/11/20 |
Shinji Suzuki
ADM | Chief Administrative Officer | 54 | 30/04/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| President | 43 | 31/05/10 | |
Shinji Suzuki
ADM | Chief Administrative Officer | 54 | 30/04/16 |
Fumiya Ito
BRD | Director/Board Member | 47 | 30/11/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2,401 | +0.92% | 24,300 |
| 25/04/24 | 2,379 | -2.66% | 7,300 |
| 24/04/24 | 2,444 | -2.86% | 23,800 |
| 23/04/24 | 2,516 | +3.54% | 8,500 |
| 22/04/24 | 2,430 | +0.96% | 18,600 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotes
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
Sector
Department Stores
Calendar
11/07/2024
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -44.16% | 75.3M | |
| +18.22% | 1,869B | |
| +5.02% | 46.43B | |
| +41.51% | 41.08B | |
| -0.17% | 8.67B | |
| -16.80% | 7.91B | |
| +7.09% | 6.41B | |
| -15.71% | 6.26B | |
| +1.81% | 6.07B | |
| +15.78% | 5.63B |
- Stock Market
- Equities
- 2934 Stock
